Alzheimer's Treatment Options
Investigational Alzheimer's Treatment with TB006 Antibody Therapy - One of Only Seven Practices in Texas
A Moment That Changes Everything
When Margaret first forgot her granddaughter’s name at a family dinner, the silence that followed lasted only seconds—but for her family, that moment changed everything. If you’re reading this, you likely know that silence. You’ve felt the weight of watching someone you love slowly slip away, one memory at a time.
Today, there’s a new reason for hope. The Texas Institute for Anti-Aging Research is one of only seven practices in Texas selected to offer TB006, an investigational antibody therapy that’s showing remarkable promise—not just in slowing Alzheimer’s progression, but in some patients, actually reversing cognitive decline. With 7 million Americans currently affected and projections reaching 25 million by 2050, this breakthrough couldn’t come at a more critical time.
The Growing Crisis
With 7 million Americans currently affected and projections reaching 25 million by 2050, this breakthrough couldn’t come at a more critical time.
Why TB006 Is Different Than Everything You've Tried
A revolutionary approach that targets the root cause rather than just managing symptoms
The Problem
Alzheimer’s develops when two abnormal proteins—beta-amyloid plaques and tau tangles—accumulate in your brain, blocking communication between cells. Think of it like traffic jams forming throughout a city’s road system. Eventually, vital messages can’t get through, and brain tissue begins to break down.
The Solution
TB006 works differently than any current treatment. It targets galectin-3, a protein that acts like molecular glue, causing harmful deposits to form. By blocking this glue, TB006 not only prevents new plaques and tangles but actually helps dissolve existing ones—potentially reversing damage rather than just slowing it.
Traditional Alzheimer's Medications vs. TB006
Current Drugs
- Manage symptoms temporarily
- Daily pills with modest benefits
- Eventually lose effectiveness
TB006
- Targets root cause, may reverse progression
- Monthly infusion with breakthrough potential
- Shows sustained improvement in some patients
Your Treatment Journey at TIFAAR
A comprehensive, personalized approach designed around your unique needs and goals
Initial Consultation (1-Hour)
We start by truly understanding your story. During this comprehensive evaluation, we:
- Review your medical history and current symptoms
- Perform cognitive assessment testing
- Discuss your goals and concerns
- Explain exactly how TB006 works and what to expect
“After two years of feeling helpless, we finally had a plan—and more importantly, we had hope.”
Qualification Testing
To ensure TB006 is right for you, we’ll need:
- Basic lab work
- EKG to assess heart function
- Brain MRI or amyloid PET scan
- Confirmation of mild to moderate Alzheimer's diagnosis
Treatment Phase
Duration
4 Months
Frequency
Once-monthly IV infusions
Setting
Our comfortable Spring, Texas facility
Support
Full medical team throughout your journey
Progress Evaluation
We track your improvement using standardized cognitive assessments and family feedback. Many patients show measurable improvement within the treatment period.
Continuous Monitoring
Our comprehensive evaluation process ensures we can track even subtle improvements and adjust your care as needed.
Your Treatment Journey at TIFAAR
A comprehensive, personalized approach designed around your unique needs and goals
Signs It's Time to Act
- Repeating questions or stories frequently
- Difficulty managing finances or medications
- Getting lost in familiar places
- Changes in judgment or decision-making
- Withdrawal from social activities
- Mood or personality changes
- Family members expressing concern
Ideal Candidates
Mild to moderate Alzheimer’s disease diagnosis
Recent onset or early-stage symptoms
Good overall health for treatment
Strong family support system
TB006 is designed for patients with mild to moderate Alzheimer’s disease. Earlier intervention typically yields better outcomes—if you’re noticing changes, don’t wait.
What Makes TIFAAR Different?
As one of only seven practices in Texas authorized to provide TB006, we combine exclusive access with exceptional care.
Exclusive Access
One of only seven practices in Texas selected to offer this breakthrough treatment.
Personalized Care
Treatment plans tailored specifically to your unique needs and circumstances.
Family-Centered
Care that supports both patients and caregivers throughout the journey.
“Every patient reminds me why we do this work. Behind every diagnosis is a lifetime of memories worth fighting for.”
Dr. Joseph Perlman
Board-Certified Medical Director
Our Comprehensive Approach
- Personalized treatment plans tailored to your specific needs
- Family-centered care that supports both patients and caregivers
- Clear communication without medical jargon
- Ongoing support beyond just medical treatment
Supporting the Whole Family
We recognize that Alzheimer’s affects entire families. That’s why we encourage loved ones to participate in consultations and treatment visits.
Caregivers often tell us that understanding the science behind TB006 helps them feel more empowered and less helpless. We provide resources, answer questions, and ensure everyone understands each step of the journey.
Safety & Side Effects
Clinical trials show TB006 has an excellent safety profile with comprehensive monitoring throughout treatment.
Excellent Safety Profile
Clinical trials show TB006 has an excellent safety profile with no serious adverse effects reported in Alzheimer’s patients.
Safety Highlights
- No serious adverse effects in trials
- FDA-approved clinical trial protocol
- Continuous medical monitoring
- Adjustable treatment rate for comfort
Mild Side Effects
The most common side effect is a mild infusion reaction—temporary symptoms that resolve quickly after treatment.
Low-grade fever
Temporary and manageable
Mild rash
Usually resolves quickly
Slight nausea
Mild and temporary
Our medical team monitors you throughout each infusion and can adjust the rate for maximum comfort.
Frequently Asked Questions
Get answers to common questions about TB006 treatment and the clinical trial process.
Is TB006 FDA-approved?
TB006 is in Phase 2A of an FDA-approved clinical trial. While not yet approved for general use, it’s being studied under strict FDA oversight.
How quickly might I see results?
Some patients show improvement during the four-month treatment period. Response varies, but we monitor progress closely throughout.
Can family members attend appointments?
Absolutely. We encourage family participation to provide insights and support throughout treatment.
What happens after the four months?
We conduct comprehensive assessments and discuss next steps based on your response and trial protocol.
How does TB006 compare to Leqembi or other new drugs?
Unlike recently approved drugs that primarily slow decline, TB006 has shown potential to actually reverse some cognitive symptoms by targeting the galectin-3 mechanism.
When will I know if it's working?
Most responding patients show measurable changes within 8-12 weeks, though some improvements may be subtle at first.
The Time To Act Is Now
Living with Alzheimer’s challenges families in profound ways, but breakthrough treatments like TB006 offer genuine hope. This isn’t just another medication that might slow decline—it’s a fundamentally different approach that could change the trajectory of this disease.
Only 7 Practices in Texas
Extremely limited availability for this exclusive treatment
Time-Sensitive Opportunity
Each month you wait is a month without access
Life-Changing Potential
Breakthrough therapy that could reverse progression
Dr. Perlman and our team at TIFAAR are ready to help you take this important step. Whether you’re seeking treatment for yourself or a loved one, we’re here to provide the expertise, support, and hope you deserve.
Don’t let this exclusive opportunity pass by.
Learn More About TB006
Watch Dr. Perlman explain this revolutionary treatment and see why TIFAAR was selected as an exclusive provider.
Fox 26 Houston Interview
Watch Dr. Perlman’s exclusive interview with Fox 26 Houston discussing the breakthrough TB006 treatment and its potential impact on Alzheimer’s care.
How TB006 Works
Learn how this revolutionary antibody therapy targets the root cause of Alzheimer’s disease and why TIFAAR was selected as one of the exclusive treatment centers.